{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:33:33Z","timestamp":1770294813732,"version":"3.49.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228415","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:37:47Z","timestamp":1582292267000},"page":"e0228415","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-7593","authenticated-orcid":true,"given":"Tanjina","family":"Kader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn M.","family":"Porteous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Dickerhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod K.","family":"Narayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedreia","family":"Tull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreya","family":"Taraknath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9857-0703","authenticated-orcid":true,"given":"Sally P. A.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"issue":"6801","key":"pone.0228415.ref001","first-page":"233","volume":"407","author":"AJ Lusis","year":"2000","journal-title":"Atherosclerosis. Nature"},{"issue":"4","key":"pone.0228415.ref002","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"C Emerging Risk Factors","year":"2009","journal-title":"JAMA"},{"issue":"2A","key":"pone.0228415.ref003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90157-9","article-title":"A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study","volume":"80","author":"WP Castelli","year":"1986","journal-title":"Am J Med"},{"issue":"4","key":"pone.0228415.ref004","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology","volume":"118","author":"BG Nordestgaard","year":"2016","journal-title":"Circulation research"},{"issue":"11","key":"pone.0228415.ref005","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study","volume":"47","author":"S Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"pone.0228415.ref006","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study","volume":"119","author":"S Tsimikas","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"pone.0228415.ref007","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1089\/ars.2010.3586","article-title":"Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities","volume":"15","author":"E Lubos","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"17","key":"pone.0228415.ref008","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa030535","article-title":"Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease","volume":"349","author":"S Blankenberg","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0228415.ref009","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.amjcard.2006.10.041","article-title":"Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis","volume":"99","author":"C Espinola-Klein","year":"2007","journal-title":"Am J Cardiol"},{"issue":"4","key":"pone.0228415.ref010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.amjcard.2008.09.104","article-title":"Effect of acute myocardial infarction on erythrocytic glutathione peroxidase 1 activity and plasma vitamin e levels","volume":"103","author":"ML Cheng","year":"2009","journal-title":"Am J Cardiol"},{"issue":"2","key":"pone.0228415.ref011","first-page":"141","article-title":"Association of glutathione peroxidase-1 (GPx-1) rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk: a meta-analysis of observational studies","volume":"11","author":"JX Zhang","year":"2014","journal-title":"J Geriatr Cardiol"},{"key":"pone.0228415.ref012","first-page":"5","article-title":"Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation","author":"D Pastori","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"pone.0228415.ref013","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"SC Lu","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"pone.0228415.ref014","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/01.STR.0000138022.86509.2d","article-title":"Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study","volume":"35","author":"H Shimizu","year":"2004","journal-title":"Stroke"},{"issue":"3","key":"pone.0228415.ref015","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.bbrc.2005.10.098","article-title":"Depressed glutathione synthesis precedes oxidative stress and atherogenesis in Apo-E(-\/-) mice","volume":"338","author":"SK Biswas","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"pone.0228415.ref016","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s00125-012-2685-z","article-title":"N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial","volume":"55","author":"AT Treweeke","year":"2012","journal-title":"Diabetologia"},{"issue":"10","key":"pone.0228415.ref017","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/jm00393a034","article-title":"Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids","volume":"30","author":"JC Roberts","year":"1987","journal-title":"J Med Chem"},{"issue":"8974","key":"pone.0228415.ref018","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(95)91385-8","article-title":"Paracetamol (acetaminophen) poisoning","volume":"346","author":"JA Vale","year":"1995","journal-title":"Lancet"},{"issue":"1\u20133","key":"pone.0228415.ref019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-4274(91)90078-K","article-title":"Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys","volume":"59","author":"JC Roberts","year":"1991","journal-title":"Toxicol Lett"},{"issue":"2","key":"pone.0228415.ref020","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.atherosclerosis.2014.10.101","article-title":"Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice","volume":"237","author":"T Kader","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"pone.0228415.ref021","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"AS Plump","year":"1992","journal-title":"Cell"},{"issue":"10","key":"pone.0228415.ref022","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/2685","article-title":"Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice","volume":"4","author":"D Pratico","year":"1998","journal-title":"Nat Med"},{"issue":"10","key":"pone.0228415.ref023","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.ATV.0000183928.25844.f6","article-title":"Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism","volume":"25","author":"M Mayr","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"pone.0228415.ref024","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.ATV.0000258809.47285.07","article-title":"Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"M Torzewski","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"pone.0228415.ref025","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2015-09-666834","article-title":"Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice","volume":"128","author":"E Hortle","year":"2016","journal-title":"Blood"},{"issue":"28","key":"pone.0228415.ref026","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.jchromb.2009.04.018","article-title":"Simultaneous determination of reduced glutathione, glutathione disulphide and glutathione sulphonamide in cells and physiological fluids by isotope dilution liquid chromatography-tandem mass spectrometry","volume":"877","author":"DT Harwood","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"pone.0228415.ref027","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"5","key":"pone.0228415.ref028","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI117915","article-title":"Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet","volume":"95","author":"DA Purcell-Huynh","year":"1995","journal-title":"J Clin Invest"},{"issue":"6","key":"pone.0228415.ref029","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"3","key":"pone.0228415.ref030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000085553","article-title":"Elastic lamina defects are an early feature of aortic lesions in the apolipoprotein E knockout mouse","volume":"42","author":"GT Jones","year":"2005","journal-title":"Journal of vascular research"},{"issue":"3","key":"pone.0228415.ref031","first-page":"265","article-title":"N-acetylcysteine: multiple clinical applications","volume":"80","author":"PJ Millea","year":"2009","journal-title":"Am Fam Physician"},{"issue":"4","key":"pone.0228415.ref032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0773.1992.tb00472.x","article-title":"Protection against acetaminophen hepatotoxicity by ribose-cysteine (RibCys)","volume":"70","author":"JC Roberts","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"pone.0228415.ref033","unstructured":"Health CTNIo. https:\/\/clinicaltrials.gov 2017 [cited 16\/7\/2017]."},{"issue":"5","key":"pone.0228415.ref034","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/019262330002800510","article-title":"Ribose cysteine protects against acetaminophen-induced hepatic and renal toxicity","volume":"28","author":"AM Lucas","year":"2000","journal-title":"Toxicol Pathol"},{"issue":"6","key":"pone.0228415.ref035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1742-7843.2005.pto_96613.x","article-title":"Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion","volume":"96","author":"AM Slitt","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"pone.0228415.ref036","doi-asserted-by":"crossref","first-page":"G553","DOI":"10.1152\/ajpgi.00547.2007","article-title":"Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols","volume":"296","author":"N Ferre","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"pone.0228415.ref037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exger.2009.11.006","article-title":"Apolipoprotein E and its role in aging and survival","volume":"45","author":"F Bonomini","year":"2010","journal-title":"Exp Gerontol"},{"issue":"9","key":"pone.0228415.ref038","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.0000026820.87824.6A","article-title":"Heterozygous Cellular Glutathione Peroxidase Deficiency in the Mouse: Abnormalities in Vascular and Cardiac Function and Structure","volume":"106","author":"MA Forgione","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"pone.0228415.ref039","doi-asserted-by":"crossref","first-page":"e72063","DOI":"10.1371\/journal.pone.0072063","article-title":"Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis","volume":"8","author":"F Cheng","year":"2013","journal-title":"PloS one"},{"key":"pone.0228415.ref040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vph.2015.11.001","article-title":"Lack of glutathione peroxidase-1 facilitates a pro-inflammatory and activated vascular endothelium","volume":"79","author":"A Sharma","year":"2016","journal-title":"Vascul Pharmacol"},{"issue":"7","key":"pone.0228415.ref041","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1253\/circj.CJ-08-1148","article-title":"N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by reducing superoxide production","volume":"73","author":"K Shimada","year":"2009","journal-title":"Circ J"},{"issue":"11","key":"pone.0228415.ref042","doi-asserted-by":"crossref","first-page":"998","DOI":"10.5551\/jat.8870","article-title":"The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-kappaB in ApoE-deficient mice","volume":"18","author":"Y Lu","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"pone.0228415.ref043","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.1038\/srep16339","article-title":"N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein","volume":"5","author":"Y Cui","year":"2015","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0228415.ref044","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1074\/jbc.274.11.7165","article-title":"Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice","volume":"274","author":"Y Ueda","year":"1999","journal-title":"Journal of Biological Chemistry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:38:21Z","timestamp":1582292301000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228415"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228415","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}